A new study, funded in part by the National Institute of Mental Health, showed that a new medication derived from ketamine is safe and acceptable for use in humans, setting the stage for clinical trials testing it for hard-to-treat mental disorders like severe depression.
from NIMH News Feed https://ift.tt/HiDZtUu
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment